Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DelotaFRA:S62 Debt-to-EBITDA is 2.96 as of Mar. 2026, which is 342% above its 10-year median of 0.67. The stock has 3 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Delota ranks worse than 62.89% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Delota's Debt-to-EBITDA or its related term are showing as below:
FRA:S62'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -2.72 Med: 0.67 Max: 7.41
Current: 3.29
During the past 12 years, the highest Debt-to-EBITDA Ratio of Delota was 7.41. The lowest was -2.72. And the median was 0.67.
FRA:S62's Debt-to-EBITDA is ranked worse than 62.89% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 2.19
vs FRA:S62: 3.29
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Delota Debt-to-EBITDA Related Terms
Delota Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Delota's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Delota's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Delota Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Delota's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Delota's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Delota (FRA:S62) has a Debt-to-EBITDA of 2.96 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Delota. This is 342% above median its historical median of 0.67. According to the industry distribution chart, Delota ranks #300 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 62.9%.
Is Delota's Debt-to-EBITDA too high?
Delota's current Debt-to-EBITDA of 2.96 is 342% above median its 10-year median of 0.67. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.19. Delota's value of 2.96 is 35.2% above this industry median. Based on the distribution chart, Delota ranks #300 out of 477 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Delota's Debt-to-EBITDA compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Delota ranks #300 out of 477 companies for Debt-to-EBITDA. This places Delota in the lower half of its industry. The industry median Debt-to-EBITDA is 2.19. Delota's value of 2.96 is 35.2% above this benchmark. While the company's 10-year median is 0.67 vs. the industry median of 2.19, Delota has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.19, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Delota's current Debt-to-EBITDA of 2.96 is 35.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Delota. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Delota's current Debt-to-EBITDA is 2.96, which is 342% above median its own 10-year median of 0.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delota stock overvalued right now?
Delota (FRA:S62) has a current Debt-to-EBITDA of 2.96. The stock's GF Value™ is €0.04, compared to a current price of €0.03 — trading 25% below its estimated fair value. The current Debt-to-EBITDA is 2.96, which is 342% above median its 10-year median of 0.67 and 35.2% above the Healthcare Providers & Services industry median of 2.19. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Delota (FRA:S62), the current Debt-to-EBITDA is 2.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Delota Corp is a cannabis and nicotine retailer. The company is engaged in developing retail cannabis and nicotine brands in Canada by growing its retail footprint and developing retail banners. The Company's flagship brand, one hundred eighty Smoke Vape Store, stands as Ontario's omni channel specialty vape retailer, fueling innovation, growth, and leadership in the nicotine vape and alternative tobacco sector. The Company operates twenty nine brick-and-mortar specialty vape stores in Ontario under the one hundred eighty Smoke Vape Store brand, a dominant national e-commerce platform and three licensed dispensaries in Ontario under the Offside Cannabis brand.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:S62 has been successfully added to your 
